サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442909

角膜インプラント - 世界市場の考察、競合情勢、市場予測（2030年）

Corneal Implant - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
角膜インプラント - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の角膜インプラントの市場規模は、2024年～2030年の予測期間にCAGRで6.43%の大幅な成長が見込まれています。角膜インプラントの需要は主に、角膜失明、眼外傷、眼圧亢進症（緑内障）などの症例の増加によって後押しされています。さらに、角膜インプラントの開発に向けたさまざまな業界参入企業のパートナーシップ活動の高まりや角膜ドナーの不足は、2024年～2030年の予測期間に市場の全体的な成長に寄与する見込みです。

角膜インプラントの市場力学

BrightFocus Foundation（2022）が提供したデータによると、世界全体で8,000万人が緑内障を患っており、この数は2040年までに1億1,100万人以上に増加すると予測されています。同じ資料によると、失明や弱視は40歳を超えた330万人の米国人に影響を与えます。さらに、世界保健機関（WHO）が発表した最新の調査データによると、角膜失明は緑内障、白内障に次ぐ失明の原因の第3位であり、全世界で約1,000万人が罹患していると結論づけられています。

このように、緑内障、角膜失明などの眼科疾患の有病率の増加は、角膜インプラントへのニーズを生み出し、角膜インプラント市場のプラス成長をもたらします。

角膜ドナーの数が限られていることも、角膜インプラント市場の促進要因の1つです。例えば、American Academy of Ophthalmology（2021）によると、約1,000万人が角膜移植を必要としているため、世界中で角膜ドナーの需要は高くなっています。このように、角膜ドナーの数が少ない、または不足していることは、角膜インプラント市場を促進する極めて重大な役割を果たします。

しかし、人工角膜の拒絶反応や、機器に関連する高いコストは、角膜インプラント市場の成長を抑制する可能性がある市場障壁です。

角膜インプラント市場のセグメント分析

角膜インプラント市場の手技セグメントでは、2023年に全層角膜移植カテゴリが大きな収益シェアを獲得すると予測されています。これは、全層角膜移植によって提供されるさまざまな利点によるものと考えられます。

角膜移植としても知られる全層角膜移植は、角膜の疾患や損傷を受けた部分を外科的に除去し、その後、健康な組織を移植するものです。この手術は、痛みを和らげ、視力を改善し、角膜領域の重度の感染症や損傷を治療するのに役立ちます。

Eye Bank Association of America（2022）によると、2021年に全層角膜移植に向けて米国から供給された組織の流通総数は7万9,641でした。上記の数字は、全層角膜移植の需要とニーズの高まりを明示しています。

したがって、上記の要因から全層角膜移植カテゴリは大きな成長を記録すると予測され、それによって予測期間の角膜インプラント市場全体の成長を促進します。

北米が角膜インプラント市場全体を独占すると予測されています

すべての地域の中で、北米が2023年に角膜インプラント市場で最大のシェアを占めると推定されています。これは、この地域の主要市場企業のプレゼンスによるものと考えられます。さらに、効率的な償還政策や、角膜インプラントに関連する研究開発活動の増加、角膜失明の負担の増加が、北米における角膜インプラント市場の成長の一因となっています。

米国疾病予防管理センター（2022）が発表したデータによると、2017年に約600万人の米国人が視力低下、100万人の米国人が失明に苦しんでいると推定されています。さらに、糖尿病や高血圧などの眼科疾患の危険因子の有病率の増加は、眼科疾患の有病率を増加させ、ひいては角膜インプラントの需要を増加させます。米国疾病予防管理センター（CDC、2020）のNational Diabetics Statistics Reportによると、2020年に約3,420万人の米国人が糖尿病に罹患しています。同レポートはさらに、約8,800万人の米国人が糖尿病予備軍であると述べています。このように、米国における眼疾患の負担の増加は、結果として角膜インプラント市場の成長の増大につながり、北米の角膜インプラント市場をさらに促進します。

当レポートでは、世界の角膜インプラント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 角膜インプラント市場レポートのイントロダクション

第2章 角膜インプラント市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 角膜インプラント市場の主な要因の分析

  • 角膜インプラント市場の促進要因
  • 角膜インプラント市場の抑制要因と課題
  • 角膜インプラント市場の機会

第5章 角膜インプラント市場のポーターのファイブフォース分析

第6章 角膜インプラント市場のレイアウト

  • 手技別
    • 内皮角膜移植
    • 全層角膜移植
    • その他
  • 疾患別
    • 円錐角膜
    • フックスジストロフィー
    • 感染性角膜炎
    • 角膜潰瘍
  • エンドユーザー別
    • 病院
    • 眼科クリニック
    • 外来手術センター
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 角膜インプラント市場の企業と製品のプロファイル

  • EyeYon
  • AJL Ophthalmic S.A.
  • KeraMed, Inc.
  • Aurolab
  • CorneaGen
  • Presbia PLC
  • LinkoCare Life Sciences AB
  • MEDIPHACOS
  • Cornea Biosciences
  • Advancing Sight Network
  • Corneat Vision
  • DIOPTEX

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Corneal Implants Market in Global (2021-2030)
  • Table 3: Corneal Implants Market in Global by Procedure (2021-2030)
  • Table 4: Corneal Implants Market in Global by Disease (2021-2030)
  • Table 5: Corneal Implants Market in Global by End-User (2021-2030)
  • Table 6: Corneal Implants Market in Global by Geography (2021-2030)
  • Table 7: Corneal Implants Market in North America (2021-2030)
  • Table 8: Corneal Implants Market in North America by Country (2021-2030)
  • Table 9: Corneal Implants Market in the United States (2021-2030)
  • Table 10: Corneal Implants Market in Canada (2021-2030)
  • Table 11: Corneal Implants Market in Mexico (2021-2030)
  • Table 12: Corneal Implants Market in Europe (2021-2030)
  • Table 13: Corneal Implants Market in Europe by Country (2021-2030)
  • Table 14: Corneal Implants Market in France (2021-2030)
  • Table 15: Corneal Implants Market in Germany (2021-2030)
  • Table 16: Corneal Implants Market in the United Kingdom (2021-2030)
  • Table 17: Corneal Implants Market in Italy (2021-2030)
  • Table 18: Corneal Implants Market in Spain (2021-2030)
  • Table 19: Corneal Implants Market in the Rest of Europe (2021-2030)
  • Table 20: Corneal Implants Market in Asia-Pacific (2021-2030)
  • Table 21: Corneal Implants Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Corneal Implants Market in China (2021-2030)
  • Table 23: Corneal Implants Market in Japan (2021-2030)
  • Table 24: Corneal Implants Market in India (2021-2030)
  • Table 25: Corneal Implants Market in Australia (2021-2030)
  • Table 26: Corneal Implants Market in South Korea (2021-2030)
  • Table 27: Corneal Implants Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Corneal Implants Market in the Rest of the World (2021-2030)
  • Table 29: Corneal Implants Market in RoW by Region (2021-2030)
  • Table 30: Corneal Implants Market in the Middle East (2021-2030)
  • Table 31: Corneal Implants Market in Africa (2021-2030)
  • Table 32: Corneal Implants Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Corneal Implants Market in Global (2021-2030)
  • Figure 3: Corneal Implants Market in Global by Procedure (2021-2030)
  • Figure 4: Corneal Implants Market in Global by Disease (2021-2030)
  • Figure 5: Corneal Implants Market in Global by End-User (2021-2030)
  • Figure 6: Corneal Implants Market in Global by Geography (2021-2030)
  • Figure 7: Corneal Implants Market in North America (2021-2030)
  • Figure 8: Corneal Implants Market in North America by Country (2021-2030)
  • Figure 9: Corneal Implants Market in the United States (2021-2030)
  • Figure 10: Corneal Implants Market in Canada (2021-2030)
  • Figure 11: Corneal Implants Market in Mexico (2021-2030)
  • Figure 12: Corneal Implants Market in Europe (2021-2030)
  • Figure 13: Corneal Implants Market in Europe by Country (2021-2030)
  • Figure 14: Corneal Implants Market in France (2021-2030)
  • Figure 15: Corneal Implants Market in Germany (2021-2030)
  • Figure 16: Corneal Implants Market in the United Kingdom (2021-2030)
  • Figure 17: Corneal Implants Market in Italy (2021-2030)
  • Figure 18: Corneal Implants Market in Spain (2021-2030)
  • Figure 19: Corneal Implants Market in the Rest of Europe (2021-2030)
  • Figure 20: Corneal Implants Market in Asia-Pacific (2021-2030)
  • Figure 21: Corneal Implants Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Corneal Implants Market in China (2021-2030)
  • Figure 23: Corneal Implants Market in Japan (2021-2030)
  • Figure 24: Corneal Implants Market in India (2021-2030)
  • Figure 25: Corneal Implants Market in Australia (2021-2030)
  • Figure 26: Corneal Implants Market in South Korea (2021-2030)
  • Figure 27: Corneal Implants Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Corneal Implants Market in the Rest of the World (2021-2030)
  • Figure 29: Corneal Implants Market in RoW by Region (2021-2030)
  • Figure 30: Corneal Implants Market in the Middle East (2021-2030)
  • Figure 31: Corneal Implants Market in Africa (2021-2030)
  • Figure 32: Corneal Implants Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0695

Corneal Implants Market By Procedure (Endothelial Keratoplasty, Penetrating Keratoplasty, And Others), Disease (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, And Others), End-User (Hospitals, Eye Clinics, And Ambulatory Surgical Centers) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of corneal blindness, eye injury, and other ophthalmic disorders and rising partnership activities for the development of corneal implants combined with increasing technological advancements in product design

The global Corneal Implants Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.43% during the forecast period from 2024 to 2030. The demand for corneal implants is primarily being boosted by the increasing cases of corneal blindness, eye injuries, ocular hypertension (glaucoma), and among others. Additionally, the rising partnership activities among various industry players for the development of corneal implants and the scarce number of cornea donors are expected to contribute to the overall growth of the corneal implants market during the forecast period from 2024-2030.

Corneal Implants Market Dynamics:

According to data provided by BrightFocus Foundation 2022, globally 80 million people are suffering from glaucoma and this number is expected to increase to over 111 million by the year 2040. As per the same source, blindness or low vision affects 3.3 million Americans after the age of 40 years. Additionally, as per the data published by the World Health Organization (WHO) in the latest study, it was concluded that corneal blindness is the third-leading cause of blindness after glaucoma and cataracts affecting around 10 million people globally.

Thus the rising prevalence of ophthalmic disorders such as glaucoma, corneal blindness, and other disorders, will create a need for corneal implants, thus resulting in the positive growth of the Corneal Implants market.

The presence of only a minimal number of corneal donors is another driver for the Corneal Implants market. For instance, according to the American Academy of Ophthalmology 2021, there is a high demand for corneal donors around the world as nearly 10 million people need corneal transplants. Thus, the presence of a low or scarce number of cornea donors will play a pivotal role in driving the Corneal Implants Market.

However, the rejection of artificial corneas and, the high costs associated with the device, are some of the market barriers that may restrict the growth of the corneal implants market.

Corneal Implants Market Segment Analysis:

Corneal Implants Market by Procedure (Endothelial Kertoplasty, Penetrating Keratoplasty, and Others), Disease (Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers, and Others), End-User (Hospitals, Eye Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the procedure segment of the Corneal Implants market, the Penetrating Keratoplasty category is expected to amass a significant revenue share in the year 2023. This can be attributed to the various advantages provided by the penetrating keratoplasty procedures.

Penetrating Keratoplasty also known as corneal transplant or corneal graft is the surgical removal of diseased or damaged portion of the cornea, which is followed by implantation of healthy tissue. The procedure helps to relieve pain, improve sight, and treat severe infection or damage in the corneal region.

According to the Eye Bank Association of America 2022, the total number of U.S.-supplied tissue distributed for penetrating keratoplasty was 79,641 in 2021. The above-mentioned figure highlights the rising demand and the need for penetrating keratoplasty procedures.

Therefore, owing to the above-mentioned factors, the penetrating keratoplasty category is expected to register significant growth, thereby driving the growth of the overall Corneal Implants market during the forecast period.

North America is expected to dominate the overall Corneal Implants Market:

Among all the regions, North America is estimated to account for the largest share of the Corneal Implants market in the year 2023. This can be attributed to the presence of major market players in the region. Additionally, efficient reimbursement policies, increasing R&D activities related to corneal implants, and increasing burden of corneal blindness are some of the contributing factors to the growth of the Corneal Implants market in North America.

According to the data published by the Centers of Disease Control and Prevention 2022, it was estimated that approximately 6 million Americans had vision loss and 1 million Americans was suffering from blindness in 2017. Additionally, increasing the prevalence of risk factors of ophthalmic disorders such as diabetes and hypertension in turn will increase the prevalence of ophthalmic disorders and ultimately increase the demand for corneal implants. As per the National Diabetics Statistics Report by the Centers for Disease Control and Prevention (CDC, 2020), about 34.2 million Americans had diabetes in 2020. The report further stated that approximately 88 million Americans showed pre-diabetes levels. Thus, the increasing burden of ocular disorders in the United States will eventually lead to an increase in the growth of the corneal implants market, which will further propel the market for corneal implants market in North America.

Moreover, the occurrence of various product development and partnership activities in the region is another driving factor for the corneal implants market. For Instance, in July 2022 Carl Zeiss Meditec and Precise Bio announced an agreement for the development and commercialization of tissue-based implants.

Thus, the factors mentioned above, are thereby responsible for driving the Corneal Implants market in the United States, which will further boost the market for Corneal Implants in North America during the forecast period.

Corneal Implants Market Key Players:

Some of the key market players operating in the Corneal Implants Market include EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, among others.

Recent Developmental Activities in the Corneal Implants Market:

  • In July 2022, Acufocus received FDA approval for AcuFocus' IC-8 Apthera. IC-8 Apthera is indicated for the treatment of cataract patients.
  • In July 2019, CorneaGen received USD 37 million in funding for the advanced development of Cornea Cell Therapy.

Key Takeaways from the Corneal Implants Market Report Study

  • Market size analysis for current Corneal Implants Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Corneal Implants market.
  • Various opportunities available for the other competitors in the Corneal Implants Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Corneal Implants Market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Corneal Implants Market growth in the coming future?

Target Audience who can be benefited from this Corneal Implants Market Report Study

  • Corneal Implants product providers
  • Research organizations and consulting companies
  • Corneal Implant -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Corneal Implants
  • Various end-users who want to know more about the Corneal Implants Market and the latest technological developments in the Corneal Implants Market.

Frequently Asked Questions for the Corneal Implants Market:

1 What is meant by Corneal Implants?

Corneal Implants are artificial corneas usually used to replace the diseased cornea of the eye via endothelial keratoplasty, penetrating keratoplasty, and other ophthalmic procedures. It is mostly used to treat ocular conditions such as corneal ulcers, corneal blindness and Fuchs Dystrophy.

2 What is the market for global Corneal Implants Market?

The global Corneal Implants Market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.43% during the forecast period from 2024 to 2030.

3 What are the drivers for the global Corneal Implants market?

The Corneal Implants Market is slated to witness prosperity owing to factors such as the growing incidence of corneal blindness, eye injury, and other ophthalmic procedures. Additionally, scare number of cornea donors and rising number of partnerships for the development of corneal implants, are some of the factors which can result in appreciable revenue growth in the Corneal Implants Market during the forecast period (2024-2030).

4 Who are the key players operating in the global Corneal Implants market?

Some of the key market players operating in the Corneal Implants Market include EyeYon, AJL Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight Network, Corneat Vision, DIOPTEX, among others.

5. Which region has the highest share in the global Corneal Implants market?

North America is expected to dominate the overall Corneal Implants Market during the forecast period, 2024 to 2030. This can be attributed to the presence of major players in the region, efficient reimbursement policies, increasing R&D activities related to corneal implants, increasing burden of corneal blindness, and rising elderly population prone to ophthalmic diseases are some of the factors influencing the positive growth of the market in the region during the forecast period.

Table of Contents

1. Corneal Implants Market Report Introduction

2. Corneal Implants Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Corneal Implants Market Key Factors Analysis

  • 4.1. Corneal Implants Market Drivers
    • 4.1.1. Increasing incidence of corneal blindness, eye injury and other ophthalmic disorders
    • 4.1.2. Low number of cornea donors
    • 4.1.3. Rising number of partnership activities for the development of corneal implants
  • 4.2. Corneal Implants Market Restraints and Challenges
    • 4.2.1. Rejection of Artificial Corneas
    • 4.2.2. High Cost of devices
  • 4.3. Corneal Implants Market Opportunities
    • 4.3.1. Improving product safety and biocompatibility
    • 4.3.2. Rising development of 3D printed artificial corneas

5. Corneal Implants Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Corneal Implants Market Layout

  • 6.1. By Procedure
    • 6.1.1. Endothelial Kertoplasty
    • 6.1.2. Penetrating Keratoplasty
    • 6.1.3. Others
  • 6.2. By Disease
    • 6.2.1. Keratoconus
    • 6.2.2. Fuchs Dystrophy
    • 6.2.3. Infectious Keratitis
    • 6.2.4. Corneal Ulcers
    • 6.2.5. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Eye Clinics
    • 6.3.3. Ambulatory Surgical Centers
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Corneal Implants Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Corneal Implants Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.3. India Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Corneal Implants Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Corneal Implants Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Corneal Implants Market Size in USD million (2021-2030)

7. Corneal Implants Market Company and Product Profiles

  • 7.1. EyeYon
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. AJL Ophthalmic S.A.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. KeraMed, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Aurolab
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. CorneaGen
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Presbia PLC
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. LinkoCare Life Sciences AB
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. MEDIPHACOS
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Cornea Biosciences
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Advancing Sight Network
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Corneat Vision
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. DIOPTEX
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us